Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Martine F. Thijs‑Visser"'
Autor:
Evelien J M Kuip, Wendy H Oldenmenger, Martine F Thijs-Visser, Peter de Bruijn, Astrid W Oosten, Esther Oomen-de Hoop, Stijn L W Koolen, Carin C D Van der Rijt, Ron H J Mathijssen
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198289 (2018)
The transdermal fentanyl patch is widely used to treat cancer-related pain despite its wide inter- and intrapatient variability in pharmacokinetics. The aim of this study was to investigate whether smoking and body size (i.e. body mass index) influen
Externí odkaz:
https://doaj.org/article/566727907ab946afb5783ce445b86a14
Autor:
Martine F Thijs-Visser, Mijntje B. Vastbinder, Liesbeth E. M. Struik, Hanneke J. M. Zuetenhorst, Justin D. Westenberg, C. Louwrens Braal, Koen M. W. T. Lommen, Ron H.J. Mathijssen, Robbert J. van Alphen, Stijn L.W. Koolen, Agnes Jager, Esther Oomen-de Hoop, Peter de Bruijn, Quirine C. van Rossum-Schornagel
Publikováno v:
Clinical Pharmacokinetics, 61(4), 527-537. Adis
Background: Endoxifen is the most important active metabolite of tamoxifen. Several retrospective studies have suggested a minimal or threshold endoxifen systemic concentration of 14–16 nM is required for a lower recurrence rate. The aim of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2284dea60a5044e1d335b11be933342
https://pure.eur.nl/en/publications/b67beed5-f844-4074-a150-898c7b3e6de5
https://pure.eur.nl/en/publications/b67beed5-f844-4074-a150-898c7b3e6de5
Autor:
C Louwrens, Braal, Agnes, Jager, Esther Oomen-de, Hoop, Justin D, Westenberg, Koen M W T, Lommen, Peter, de Bruijn, Mijntje B, Vastbinder, Quirine C, van Rossum-Schornagel, Martine F, Thijs-Visser, Robbert J, van Alphen, Liesbeth E M, Struik, Hanneke J M, Zuetenhorst, Ron H J, Mathijssen, Stijn L W, Koolen
Publikováno v:
Clinical pharmacokinetics. 61(4)
Endoxifen is the most important active metabolite of tamoxifen. Several retrospective studies have suggested a minimal or threshold endoxifen systemic concentration of 14-16 nM is required for a lower recurrence rate. The aim of this study was to inv
Autor:
C. Louwrens Braal, Stefan A.J. Buck, Roelof W F van Leeuwen, Monique E. M. M. Bos, Daniëlle Mathijssen van Stein, Teun van Gelder, Martine F Thijs-Visser, Esther Oomen-de Hoop, Peter de Bruijn, Koen G A M Hussaarts, Agnes Jager, Ron H.J. Mathijssen, Mijntje B. Vastbinder, Stijn L.W. Koolen, Lieke Seuren, Hanneke J. M. Zuetenhorst
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Res Treat
Breast Cancer Research and Treatment, 184(1), 107-113. SPRINGER
Breast Cancer Research and Treatment, 184(1), 107-113. Springer New York
Breast Cancer Res Treat
Breast Cancer Research and Treatment, 184(1), 107-113. SPRINGER
Breast Cancer Research and Treatment, 184(1), 107-113. Springer New York
Background Many cancer patients use additional herbs or supplements in combination with their anti-cancer therapy. Green tea—active ingredient epigallocatechin-3-gallate (EGCG)—is one of the most commonly used dietary supplements among breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370a440a75969aa38d2f154a6b5408df
https://doi.org/10.1007/s10549-020-05829-6
https://doi.org/10.1007/s10549-020-05829-6
Autor:
Hanneke J. M. Zuetenhorst, Roelof W F van Leeuwen, Esther Oomen‑deHoop, Koen G A M Hussaarts, Monique E. M. M. Bos, Peter de Bruijn, Stefan A.J. Buck, Daniëlle Mathijssen van Stein, Teun van Gelder, Mijntje B. Vastbinder, Lieke Seuren, Ron H.J. Mathijssen, Martine F. Thijs‑Visser, Agnes Jager, Stijn L.W. Koolen, C. Louwrens Braal
Publikováno v:
Breast Cancer Research and Treatment. 185:889-889
Unfortunately, the original version of the article was published with incorrect copyright as “© Springer Science + Business Media, LLC, part of Springer Nature 2020”.
Autor:
T. van Gelder, L. Braal, Martine F Thijs-Visser, M.M.E.M. Bos, Lieke Seuren, R. van Leeuwen, Stefan A.J. Buck, J.M. Zuetenhorst, D. Mathijssen-van Stein, Stijn L.W. Koolen, E. Oomen-de Hoop, P. de Bruijn, Mijntje B. Vastbinder, Ron H.J. Mathijssen, Koen G A M Hussaarts
Publikováno v:
Annals of Oncology. 31:S324
Autor:
Carin C.D. van der Rijt, Stijn L.W. Koolen, Ron H.J. Mathijssen, Wendy H. Oldenmenger, Peter de Bruijn, Evelien J. M. Kuip, Martine F Thijs-Visser, Esther van Meerten, Gerda M. Verduijn, Esther Oomen-de Hoop
Publikováno v:
Cancers, Vol 10, Iss 11, p 445 (2018)
Cancers, 10, 11
Cancers
Volume 10
Issue 11
Cancers, 10(11):445. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 10
Cancers, 10, 11
Cancers
Volume 10
Issue 11
Cancers, 10(11):445. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 10
Over 90% of patients treated for head and neck cancer with curatively aimed chemo or bioradiotherapy will develop painful mucositis and xerostomia. Sublingually delivered fentanyl (SDL) is a rapid acting opioid to treat breakthrough pain. It is uncle
Autor:
Peter de Bruijn, Ron H.J. Mathijssen, Wendy H. Oldenmenger, Evelien J. M. Kuip, Carin C.D. van der Rijt, Martine F. Thijs‑Visser, Astrid W. Oosten, Stijn L.W. Koolen, Esther Oomen-de Hoop
Publikováno v:
PLoS One, 13
PLoS One (online), 13(6):e0198289. Public Library of Science
PLoS One, 13, 6
PLoS ONE, Vol 13, Iss 6, p e0198289 (2018)
PLoS ONE
PLoS One (online), 13(6):e0198289. Public Library of Science
PLoS One, 13, 6
PLoS ONE, Vol 13, Iss 6, p e0198289 (2018)
PLoS ONE
Contains fulltext : 193542.pdf (Publisher’s version ) (Open Access) The transdermal fentanyl patch is widely used to treat cancer-related pain despite its wide inter- and intrapatient variability in pharmacokinetics. The aim of this study was to in